Nanoparticles as potential clinical therapeutic agents in Alzheimer’s disease: focus on selenium nanoparticles

QRコード

Nanoparticles as potential clinical therapeutic agents in Alzheimer’s disease: focus on selenium nanoparticles

Introduction: In etiology of Alzheimer’s disease (AD), involvement of amyloid β (Aβ) plaque accumulation and oxidative stress in the brain have important roles. Several nanoparticles such as titanium dioxide, silica dioxide, silver and zinc oxide have been experimentally using for treatment of neuro...

書誌詳細
出版年:	Expert Review of Clinical Pharmacology
第一著者:	2-s2.0-85021103809
フォーマット:	Review
言語:	English
出版事項:	Taylor and Francis Ltd 2017
オンライン･アクセス:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021103809&doi=10.1080%2f17512433.2017.1324781&partnerID=40&md5=c4279183e800673b1cd805c82ffadca3

類似資料

Exploration of synthetic multifunctional amides as new therapeutic agents for Alzheimer's disease through enzyme inhibition, chemoinformatic properties, molecular docking and dynamic simulation insights
著者:: 2-s2.0-85053905014
出版事項: (2018)

Synthesis, enzyme inhibitory kinetics mechanism and computational study of N-(4-methoxyphenethyl)-N-(substituted)- 4-methylbenzenesulfonamides as novel therapeutic agents for Alzheimer's disease
著者:: 2-s2.0-85049259205
出版事項: (2018)

Synthesis, biological evaluation, molecular docking and dynamic simulation of novel benzofuran derivatives as potential agents against Alzheimer's disease
著者:: 2-s2.0-85206074124
出版事項: (2025)

Synthesis of Some New N-Alkyl/Aralkyl-N-(2,3-Dihydro-1,4-Benzodioxin-6-YL)-4-Bromobenzenesulfonamides as Possible Therapeutic Agents F or Alzheimer’s Disease
著者:: 2-s2.0-85127408369
出版事項: (2022)

Synthesis, biological and computational evaluation of benzoxazole hybrid analogs as potential anti-Alzheimer's agents
著者:: 2-s2.0-85204151475
出版事項: (2024)

Synthesis of some new N-(alkyl/aralkyl)-N-(2,3-dihydro-1,4-benzodioxan-6-yl)-4-chlorobenzenesulfonamides as possible therapeutic agents for Alzheimer’s disease and Type-2 Diabetes
著者:: 2-s2.0-85061745776
出版事項: (2019)

Increasing grain selenium concentration via genetic and agronomic innovations
著者:: 2-s2.0-85171630656
出版事項: (2024)

Synthesis, molecular docking, acetylcholinesterase and butyrylcholinesterase inhibitory potential of thiazole analogs as new inhibitors for Alzheimer disease
著者:: 2-s2.0-84940020718
出版事項: (2015)

Increasing grain selenium concentration via genetic and agronomic innovations
著者:: Daud M.F.B.; Rempelos L.; Cakmak I.; Leifert C.; Bilsborrow P.
出版事項: (2024)

Synthesis, In Vitro Biological Evaluation and Molecular Modeling of Benzimidazole-Based Pyrrole/Piperidine Hybrids Derivatives as Potential Anti-Alzheimer Agents
著者:: 2-s2.0-85191352219
出版事項: (2024)

Streptozotocin mechanisms and its role in rodent models for Alzheimer’s disease
著者:: 2-s2.0-85144019319
出版事項: (2023)

Unveiling the Biomedical Applications of Zinc Oxide (ZnO) Nanoparticles: A Review Fostering on the Synthesis, Therapeutics and Imaging with Recent Developments
著者:: Cheng Z.; Janakiraman A.K.; Gunasekaran B.; Ying C.L.S.; Hanif E.A.B.M.; Chellammal H.S.J.; Djearamane S.
出版事項: (2024)

Disease History, Pathogenesis, Diagnostics, and Therapeutics for Human Monkeypox Disease: A Comprehensive Review
著者:: 2-s2.0-85144741230
出版事項: (2022)

Green Synthesis of Ag, Cu and AgCu Nanoparticles using Palm Leaves Extract as the Reducing and Stabilizing Agents
著者:: 2-s2.0-85050612407
出版事項: (2018)

Antibacterial and Antiviral Potential of Zirconium Oxide Nanoparticle using Extract of Chloranthus erectus Leaf
著者:: 2-s2.0-85198997740
出版事項: (2024)

Disease History, Pathogenesis, Diagnostics, and Therapeutics for Human Monkeypox Disease: A Comprehensive Review
著者:: Saied A.A.; Dhawan M.; Metwally A.A.; Fahrni M.L.; Choudhary P.; Choudhary O.P.
出版事項: (2022)

Synthesis of benzimidazole–based analogs as anti alzheimer’s disease compounds and their molecular docking studies
著者:: 2-s2.0-85093694209
出版事項: (2020)

Cellulosic fiber nanocomposite application review with zinc oxide antimicrobial agent nanoparticle: an opt for COVID-19 purpose
著者:: Azizan A.; Samsudin A.A.; Shamshul Baharin M.B.; Dzulkiflee M.H.; Rosli N.R.; Abu Bakar N.F.; Adlim M.
出版事項: (2023)

THE POTENTIAL OF RICE HUSK WASTE TO SYNTHESISE ZINC OXIDE NANOPARTICLES AND ASSESSMENT TO THE ANTIBACTERIAL ACTIVITIES
著者:: Amran, 等
出版事項: (2024)

THE POTENTIAL OF RICE HUSK WASTE TO SYNTHESISE ZINC OXIDE NANOPARTICLES AND ASSESSMENT TO THE ANTIBACTERIAL ACTIVITIES
著者:: Amran N.; Maadon S.N.; Yasin Y.; Masdek N.R.N.; Yusop M.R.; Sa’at N.H.M.; Ahmad N.M.; Hasan N.
出版事項: (2024)

Identification of Potent Inhibitors of Alzheimer's Disease Based on Benzodioxin-Thiosemicarbazide Analogues and Molecular Docking Study
著者:: 2-s2.0-85219522570
出版事項: (2025)

CHALLENGES IN DIGITALISATION OF BUILT HERITAGE IN MALAYSIA: A FOCUS GROUP PERSPECTIVE
著者:: 2-s2.0-85210893781
出版事項: (2024)

Evaluation of phytoactive contents and antibacterial activities of green synthesised cerium oxide nanoparticles using Melastoma sp. leaf extract as the capping agent
著者:: 2-s2.0-85198528995
出版事項: (2024)

The β-carboline analogs as a potent inhibitor for Alzheimer's Disease, molecular docking and dynamics simulation study
著者:: 2-s2.0-85173583185
出版事項: (2023)

New benzimidazole based Schiff bases as potent anti-alzheimer agents: Synthesis, bio-evaluation and molecular docking study
著者:: 2-s2.0-85189482031
出版事項: (2024)

Seeing the wood for the trees: Approaches to teaching and assessing clinical pharmacology and therapeutics in a problem-based learning course
著者:: 2-s2.0-42249087459
出版事項: (2008)

Astaxanthin nanoemulsion improves cognitive function and synaptic integrity in Streptozotocin-induced Alzheimer's disease model
著者:: Chik, 等
出版事項: (2025)

Identification of Potent Inhibitors of Alzheimer's Disease Based on Benzodioxin-Thiosemicarbazide Analogues and Molecular Docking Study
著者:: Taha, 等
出版事項: (2025)

Multitargeted Molecular Docking and Dynamic Simulation Studies of Bioactive Compounds from Rosmarinus officinalis against Alzheimer’s Disease
著者:: 2-s2.0-85141550803
出版事項: (2022)

Age-Related Macular Degeneration Pathophysiology and Therapeutic Potential of Tocotrienols: An Update
著者:: Sadikan M.Z.; Lambuk L.; Reshidan N.H.; Abdul Ghani N.A.; Ahmad A.I.; Ahmad Kamal M.S.; Lazaldin M.A.M.; Ahmad Hairi H.; Mohamud R.; Abdul Nasir N.A.
出版事項: (2025)

Age-Related Macular Degeneration Pathophysiology and Therapeutic Potential of Tocotrienols: An Update
著者:: Sadikan, 等
出版事項: (2025)

Synthesis of some unique carbamate derivatives bearing 2-furoyl-1-piperazine as a valuable therapeutic agents
著者:: 2-s2.0-85016141011
出版事項: (2017)

Heavy Metal Exposure-Induced Cardiovascular Diseases: Molecular Mechanisms and Therapeutic Role of Antioxidants
著者:: Ponnusamy B.; Veeraraghavan V.P.; Al-Huseini I.; Woon C.K.; Jayaraman S.; Sirasanagandla S.R.
出版事項: (2024)

Kyllinga brevifolia mediated greener silver nanoparticles
著者:: 2-s2.0-85038353406
出版事項: (2017)

Synthesis and characterization of Ni-Au bimetallic nanoparticles
著者:: 2-s2.0-84928541471
出版事項: (2015)

Synthesis, characterization, and antimicrobial properties of copper nanoparticles
著者:: 2-s2.0-84888157808
出版事項: (2013)

Ni nanoparticles: Study of particles formation and agglomeration
著者:: 2-s2.0-84900532446
出版事項: (2012)

Overview on postmenopausal osteoporosis and periodontitis: The therapeutic potential of phytoestrogens against alveolar bone loss
著者:: 2-s2.0-85149747382
出版事項: (2023)

Synthesis, biological evaluation, and molecular docking study of novel 1,2,4-substituted triazoles as inhibitors of alzheimer’s disease
著者:: 2-s2.0-85136203736
出版事項: (2022)

2-Furoic piperazide derivatives as promising drug candidates of type 2 diabetes and Alzheimer's diseases: In vitro and in silico studies
著者:: 2-s2.0-85053836045
出版事項: (2018)